Friday, 13 Dec 2019

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Comparison of Ixekizumab and Adalimumab...

20 Nov 2019

The RheumNow Week in Review – EULAR18...

22 Jun 2018

RheumNow Weekly Podcast – 3 Wiseguy...

09 Nov 2018

Dr. David Liew: Yellow Fever...

22 Oct 2018

Dr. Artie Kavanaugh at EULAR 2018 -...

15 Jun 2018

The RheumNow Week in Review – Why...

04 May 2018

Dr. George Martin: mimics of autoimmune...

02 Mar 2016

Dr. Paul Sufka: Rheumatology Journal...

05 Nov 2017

RheumNow Podcast – Boiling Hot MAS (7....

11 Jul 2019

Dr. Len Calabrese - EULAR 2018...

20 Jun 2018

RheumNow Week in Review – Medical...

07 Sep 2018

RheumNow Podcast – Antibiotics...

16 Aug 2019